GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 11,180
+1,270 (12.82%)
At close: Oct 1, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 200.75 billion as of October 1, 2026. Its market cap has increased by 18.46% in one year.
Market Cap
200.75B
Enterprise Value
286.55B
Revenue
192.21B
Ranking
n/a
PE Ratio
41.56
Stock Price
11,180.00
ChartMarket Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 200.75B, a decrease of -9.53%. That is a compound annual growth rate of -1.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 200.75B | 23.77% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 233.22B |
| DAE HWA Pharmaceutical | 212.96B |
| CellBion | 193.19B |
| NOVAREX | 174.60B |
| HYUNDAI BIOLAND | 170.10B |
| Vivozon Pharmaceutical | 167.56B |
| Cosmax Nbt | 149.43B |
| Kyung Dong Pharmaceutical | 147.67B |